Beyond Outcomes: A Business Case for the Light Adjustable Lens™

Successful optimization of the Light Adjustable Lens™ (LAL®) technology can have a positive ripple effect in your practice and beyond. Neel Vaidya, MD, with Chicago Cornea Consultants in Chicago, IL, shares practice pearls on how they made the economics of this technology work for them, and real-world insights on how this shared confidence can inspire […]

A Collaborative Approach to Success with the Light Adjustable Lens™

Crafting successful outcomes with the Light Adjustable Lens™ (LAL®) starts with your team. Evan Schoenberg, MD, with Georgia Eye Partners in Atlanta, GA, breaks down how he applies a collaborative approach to Light Adjustable Lens treatments. He discusses how to clearly define roles within your team structure, from technicians to co-managing doctors, and the importance […]

Seamless Transition: Aligning Team Communication for a Smooth Light Adjustable Lens™ Journey

To incorporate the best technology, you first need to have a great workflow. Joaquin De Rojas, MD, with Center For Sight in Sarasota, FL, shares practice pearls for seamlessly integrating Light Adjustable Lens™ (LAL®). He shares his practice’s integration journey—focusing on strong communication skills and the collaborative care model—and how they work together to deliver […]

Seeing the Light: Discovering that the Light Adjustable Lens™ Will Succeed in Your Practice

Matt Kaufman, MD, with Eye Health Northwest in Portland, OR, shares how his practice saw a large increase in ROI after successfully integrating the Light Adjustable Lens™ (LAL®). However, this success didn’t come overnight. He and his team started by getting comfortable with the surgical technique, patient counseling and scheduling, and delivering light adjustments. One […]

LAL patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

The Light Adjustable Lens provides optimized vision for patient satisfaction.2

Light Adjustable Lens patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

Since the Light Adjustable Lens is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to potentially enhanced vision and patient satisfaction.

LAL patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The Light Adjustable Lens offers LASIK-like accuracy in cataract surgery.2,3

92% of eyes (N = 391) achieved results within 0.50 D of target manifest refraction spherical equivalent (MRSE).

Patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.

The Light Adjustable Lens corrects as low as 0.50 D of astigmatism, which is the lowest level approved to be treated.

The ability to treat 0.50 D of postoperative cylinder makes the Light Adjustable Lens the only IOL in the United States approved to correct this level of vision-altering astigmatism. Astigmatism of as little as 0.50 D can reduce visual acuity by one line, and the impact on dynamic, functional visual acuity and low-contrast acuity is even greater.1